Ekblad H, Ruuskanen O, Lindberg R, Iisalo E
J Antimicrob Chemother. 1985 Apr;15(4):489-94. doi: 10.1093/jac/15.4.489.
Serum chloramphenicol levels were evaluated in 52 children with severe infection treated intravenously with chloramphenicol succinate and orally with chloramphenicol palmitate, chloramphenicol monostearoylglycolate or chloramphenicol in capsules. Effective serum levels were recorded with all chloramphenicol preparations. The variability was largest with chloramphenicol monostearoylglycolate. In a case of neonatal Escherichia coli meningitis good serum levels of chloramphenicol were achieved with chloramphenicol palmitate orally, supporting the view that oral chloramphenicol palmitate can be used to treat serious infections in this age group. Our data and those in the literature show that monitoring of serum chloramphenicol levels in neonates is necessary. After the neonatal period monitoring of serum chloramphenicol levels is useful in avoiding too high concentrations. On the other hand, toxic effects of high concentrations can be recognized from reticulocyte and haemoglobin, neutrophil and platelet counts, which should be performed every three to four days.
对52例严重感染儿童的血清氯霉素水平进行了评估,这些儿童静脉注射琥珀氯霉素,并口服棕榈氯霉素、氯霉素单硬脂酰甘醇酸酯或胶囊装氯霉素。所有氯霉素制剂均记录到有效血清水平。氯霉素单硬脂酰甘醇酸酯的变异性最大。在1例新生儿大肠杆菌脑膜炎病例中,口服棕榈氯霉素达到了良好的氯霉素血清水平,支持了口服棕榈氯霉素可用于治疗该年龄组严重感染的观点。我们的数据和文献中的数据表明,有必要监测新生儿的血清氯霉素水平。新生儿期过后,监测血清氯霉素水平有助于避免浓度过高。另一方面,高浓度的毒性作用可通过网织红细胞和血红蛋白、中性粒细胞和血小板计数来识别,应每三到四天进行一次。